Z-2104-2025 Class II Ongoing

Recalled by Boston Scientific Corporation — Saint Paul, MN

FDA device recall Z-2104-2025 was initiated by Boston Scientific Corporation on Jun 10, 2025 and is designated Class II. Reason for recall: Potential for hole in the Tyvek layer of the sterile barrier pouch, which may compromise device sterility. Issue could potentially lead to systemic infection and sepsis in worst case scenario… The recall status is ongoing. Affected quantity: 14,724.

Recall details

Product Type
Devices
Report Date
Jul 16, 2025
Initiation Date
Jun 10, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
14,724

Product description

VersaCross RF Wire (VXW). Indicated for creation of an atrial septal defect in the heart. Product ID VXW0002 Device approved and commercialized in Japan only.

Reason for recall

Potential for hole in the Tyvek layer of the sterile barrier pouch, which may compromise device sterility. Issue could potentially lead to systemic infection and sepsis in worst case scenario. Potential punctures may go undetected in clinical settings due to small size and variable location.

Distribution pattern

Worldwide distribution - US Nationwide and the countries of Canada, Hong Kong, and Japan.

Code information

UDI-DI 00685447006121 Lot 35935598

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2104-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2104-2025. Report a data issue: hello@regdatalab.com.